Individualized cancer vaccines and antibody-drug conjugates will be among the dominant biotech innovations in cancer next ...

In recent years, there has been a noted increase in the rates of chronic disease, as well as a growth in the number of ...

The stock's fall snapped a four-day winning streak.

Read here for the advantages and risks of Morgan Stanley's Series A preferred shares vs. CoCos, with insights on market ...

Jim Lacamp, Morgan Stanley Wealth Management senior vice president, joins CNBC's 'Money Movers' to discuss his outlook on the ...

The Morgan Stanley executive is retiring to run a foundation she started that aims to bring more young women into wealth ...

A portfolio of Brightview Senior Living communities spanning four markets, including Philadelphia, has sold to one of America ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...

Morgan Stanley analyst Terence Flynn notes that BioNTech (BNTX) announced last week that it had reached a settlement agreement with the ...

Turkey has initiated an antidumping investigation into the imports of certain steel products from China and South Korea. The ...

Morgan Stanley maintains a solid balance sheet, with assets reaching $1.26t and shareholder equity rising to $103.6b. Read ...

Morgan Stanley’s stock (NYSE: MS) gained over 30% year-to-date. This compares to rival Goldman Sachs stock, which has seen ...